Table of Contents
Volume 4 | Issue 3
Publication Date: September 2004- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
150 |
Dihydopyrimidine Dehydrogenase: A Critical Molecular Biomarker for 5-Fluorouracil Toxicity Edward Chu |
|
Meeting Highlights | ||
154-158 |
Highlights From: 40th Annual Meeting of the American Society of Clinical Oncology; New Orleans, LA; June 2004 David Lee, G. Kesava Reddy, Amy Ulfers, Edward Chu, Vinay K. Jain |
|
Research in Brief | ||
159-162 |
Anti–Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer David Lee, Edward Chu, Vinay K. Jain |
|
Comprehensive Reviews | ||
163-180 |
Topoisomerase I Inhibitors in the Treatment of Gastrointestinal Cancer: From Intravenous to Oral Administration Isa E.L.M. Kuppens, Jos H. Beijnen, Jan H.M. Schellens |
|
181-189 |
Dihydropyrimidine Dehydrogenase Deficiency, a Pharmacogenetic Syndrome Associated with Potentially Life-Threatening Toxicity Following 5-Fluorouracil Administration Hany Ezzeldin, Robert Diasio |
|
190-195 |
The Role of Pemetrexed in the Treatment of Gastrointestinal Malignancy Howard S. Hochster |
|
196-203 |
Current Status of Clinical Studies for Colorectal Cancer in Taiwan Li-Tzong Chen, Jacqueline Whang-Peng |
|
Commentary | ||
204-205 |
Roles of Infusional High-Dose 5-Fluorouracil with Leucovorin in Advanced Colorectal Cancer Jin-Hwang Liu |
|